Standout Papers

Lapatinib plus Capecitabine for HER2-Positive Advanced Breast Cancer 2005 2026 2012 2019 2.4k
  1. Lapatinib plus Capecitabine for HER2-Positive Advanced Breast Cancer (2006)
    Charles E. Geyer, Deborah Lindquist et al. New England Journal of Medicine
  2. Randomized Trial of Letrozole Following Tamoxifen as Extended Adjuvant Therapy in Receptor-Positive Breast Cancer: Updated Findings from NCIC CTG MA.17 (2005)
    Paul E. Goss, James N. Ingle et al. JNCI Journal of the National Cancer Institute
  3. 2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours (2010)
    Matti Aapro, Julia Bohlius et al. European Journal of Cancer
  4. The benefits and harms of breast cancer screening: an independent review (2013)
    Michael Marmot, Douglas G. Altman et al. British Journal of Cancer
  5. 11 years' follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive early breast cancer: final analysis of the HERceptin Adjuvant (HERA) trial (2017)
    David Cameron, Martine Piccart et al. The Lancet
  6. Triple-negative breast cancer: disease entity or title of convenience? (2010)
    Lisa A. Carey, Eric P. Winer et al. Nature Reviews Clinical Oncology
  7. Swallowing Function After Stroke (1999)
    Giselle Mann, Graeme J. Hankey et al. Stroke
  8. Breast-conserving surgery with or without irradiation in women aged 65 years or older with early breast cancer (PRIME II): a randomised controlled trial (2015)
    Ian Kunkler, Linda Williams et al. The Lancet Oncology
  9. Identification of molecular apocrine breast tumours by microarray analysis (2005)
    Pierre Farmer, Hervé Bonnefoi et al. Oncogene
  10. Breast-Conserving Surgery with or without Irradiation in Early Breast Cancer (2023)
    Ian Kunkler, Linda Williams et al. New England Journal of Medicine

Immediate Impact

9 by Nobel laureates 4 from Science/Nature 103 standout
Sub-graph 1 of 17

Citing Papers

The Lancet women and cardiovascular disease Commission: reducing the global burden by 2030
2021 Standout
Breast cancer
2021 Standout
74 intermediate papers

Works of David Cameron being referenced

Breast-conserving surgery with or without irradiation in women aged 65 years or older with early breast cancer (PRIME II): a randomised controlled trial
2015 Standout
Intent-to-treat analysis of the placebo-controlled trial of letrozole for extended adjuvant therapy in early breast cancer: NCIC CTG MA.17
2008
and 39 more

Author Peers

Author Last Decade Papers Cites
David Cameron 13235 6855 4621 5550 526 23.2k
Fátima Cardoso 13308 10189 4736 7161 391 24.3k
Karen A. Gelmon 15458 6840 6371 5516 389 23.1k
Jonas Bergh 15296 11360 4816 10934 510 28.3k
Edith A. Perez 20395 10865 5671 6462 395 29.5k
George W. Sledge 14481 9362 6145 7375 435 24.8k
Lisa A. Carey 15568 11762 5129 7082 412 25.0k
Susan G. Hilsenbeck 9650 5506 3330 9836 335 21.5k
Antonio C. Wolff 15460 10354 4737 5361 352 24.0k
Vicente Valero 16929 12970 4789 5329 495 27.2k
Pierfranco Conté 16376 6245 7447 5548 684 25.1k

All Works

Loading papers...

Rankless by CCL
2026